Your browser doesn't support javascript.
loading
Development of evidence-based consensus on critical issues in the management of patients with vitiligo: A modified Delphi study.
Bae, Jung Min; Jeong, Ki-Heon; Choi, Chong Won; Park, Ji Hun; Lee, Hee Jung; Kim, Hee Jung; Lee, Sang Hoon; Oh, Sang Ho; Shin, Jeonghyun; Kang, Hee Young; Lee, Weon Ju; Ju, Hyun Jeong; Kim, Dong Hyun; Chang, Sung Eun; Lee, Dong Youn; Kim, You Chan; Choi, Gwang Seong; Kim, Ki-Ho; Kim, Tae Heung; Lee, Seung Chul; Lee, Ai-Young; Hann, Seung-Kyung; Lee, Mu-Hyoung; Park, Chul Jong.
Afiliação
  • Bae JM; Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Jeong KH; Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, South Korea.
  • Choi CW; Department of Dermatology, Chungnam National University School of Medicine, Daejeon, South Korea.
  • Park JH; Drs Woo and Hann's Skin Center, Seoul, South Korea.
  • Lee HJ; Department of Dermatology, Cha University Bundang Cha Medical Center School of Medicine, Bundang, South Korea.
  • Kim HJ; YK Park Yoon Kee's Dermatology Clinic, Seoul, South Korea.
  • Lee SH; Department of Dermatology, Soon Chun Hyang University Hospital, Bucheon, South Korea.
  • Oh SH; Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Shin J; Department of Dermatology, Inha University School of Medicine, Incheon, South Korea.
  • Kang HY; Department of Dermatology, Ajou University School of Medicine, Suwon, South Korea.
  • Lee WJ; Department of Dermatology, Kyungpook National University School of Medicine, Daegu, South Korea.
  • Ju HJ; Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim DH; Department of Dermatology, Cha University Bundang Cha Medical Center School of Medicine, Bundang, South Korea.
  • Chang SE; Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee DY; Department of Dermatology, SungKyunKwann University School of Medicine, Seoul, South Korea.
  • Kim YC; Department of Dermatology, Ajou University School of Medicine, Suwon, South Korea.
  • Choi GS; Department of Dermatology, Inha University School of Medicine, Incheon, South Korea.
  • Kim KH; Department of Dermatology, Dong-A University School of Medicine, Busan, South Korea.
  • Kim TH; White Line Skin Clinic, Changwon, South Korea.
  • Lee SC; Department of Dermatology, Chonnam National University School of Medicine, Gwangju, South Korea.
  • Lee AY; Department of Dermatology, Dongkuk University School of Medicine, Ilsan, Korea.
  • Hann SK; Drs Woo and Hann's Skin Center, Seoul, South Korea.
  • Lee MH; Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, South Korea.
  • Park CJ; Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Photodermatol Photoimmunol Photomed ; 37(1): 3-11, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32910540
ABSTRACT
BACKGROUND/

PURPOSE:

Vitiligo remains a major challenge in dermatology. However, much of the treatment remains unclear, because little evidence is available. We sought to answer some critical questions pertaining to management of vitiligo patients.

METHODS:

A modified Delphi process among 31 vitiligo experts was conducted. A total of 12 clinical vitiligo treatment questions without clear answers were collected via a vote. To address each question, two members performed systematic literature reviews and prepared draft statements along with the levels of evidence and strength of recommendation. After reviewing the draft, all expressed their extent of agreement from 1 (strong disagreement) to 9 (strong agreement) for each item. The drafts were revised to reflect suggested comments. Discussion continued until all members agreed with the ultimate decision.

RESULTS:

The consensus process was completed after five rounds. We identified the best answers to 12 key questions, including issues on long-term phototherapy, systemic and topical corticosteroids, topical calcineurin inhibitors, immunosuppressants, excimer laser treatment, and surgical interventions.

CONCLUSION:

This consensus would complement current guidelines and aid both physician and patient decision-making in the treatment of vitiligo.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitiligo / Medicina Baseada em Evidências Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitiligo / Medicina Baseada em Evidências Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article